These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 7577660
1. Corticosteroid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia. Maung ZT, Reid MM, Matheson E, Taylor PR, Proctor SJ, Hall AG. Br J Haematol; 1995 Sep; 91(1):93-100. PubMed ID: 7577660 [Abstract] [Full Text] [Related]
2. Raised intracellular glutathione levels correlate with in vitro resistance to cytotoxic drugs in leukaemic cells from patients with acute lymphoblastic leukemia. Maung ZT, Hogarth L, Reid MM, Proctor SJ, Hamilton PJ, Hall AG. Leukemia; 1994 Sep; 8(9):1487-91. PubMed ID: 8090028 [Abstract] [Full Text] [Related]
3. Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia. Pieters R, Huismans DR, Loonen AH, Hählen K, van der Does-van den Berg A, van Wering ER, Veerman AJ. Lancet; 1991 Aug 17; 338(8764):399-403. PubMed ID: 1678081 [Abstract] [Full Text] [Related]
4. In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia. Styczynski J, Pieters R, Huismans DR, Schuurhuis GJ, Wysocki M, Veerman AJ. Br J Haematol; 2000 Sep 17; 110(4):813-8. PubMed ID: 11054062 [Abstract] [Full Text] [Related]
5. Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia. Pieters R, Kaspers GJ, van Wering ER, Huismans DR, Loonen AH, Hählen K, Veerman AJ. Leukemia; 1993 Mar 17; 7(3):392-7. PubMed ID: 8445945 [Abstract] [Full Text] [Related]
6. In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. Pieters R, Loonen AH, Huismans DR, Broekema GJ, Dirven MW, Heyenbrok MW, Hählen K, Veerman AJ. Blood; 1990 Dec 01; 76(11):2327-36. PubMed ID: 2257305 [Abstract] [Full Text] [Related]
8. Expression of multidrug resistance (MDR) proteins and in vitro drug resistance in acute leukemias. Fazlina N, Maha A, Jamal R, Zarina AL, Cheong SK, Hamidah H, Ainoon O, Zulkifli SZ, Hamidah NH. Hematology; 2007 Feb 01; 12(1):33-7. PubMed ID: 17364990 [Abstract] [Full Text] [Related]
9. Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. Kaspers GJ, Veerman AJ, Popp-Snijders C, Lomecky M, Van Zantwijk CH, Swinkels LM, Van Wering ER, Pieters R. Med Pediatr Oncol; 1996 Aug 01; 27(2):114-21. PubMed ID: 8649318 [Abstract] [Full Text] [Related]
10. Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia. Savaşan S, Buck S, Ozdemir O, Hamre M, Asselin B, Pullen J, Ravindranath Y. Leuk Lymphoma; 2005 Jun 01; 46(6):833-40. PubMed ID: 16019527 [Abstract] [Full Text] [Related]
11. Biological and clinical significance of in vitro prednisolone resistance in adult acute lymphoblastic leukaemia. Tosi P, Visani G, Ottaviani E, Manfroi S, Tura S. Eur J Haematol; 1996 Aug 01; 57(2):134-41. PubMed ID: 8856090 [Abstract] [Full Text] [Related]
12. The analysis of correlations between drug resistance and clinical/laboratory measures found in a group of children with all treated by ALL-BFM 90 protocol. Mihal V, Hajduch M, Noskova V, Janostakova A, Safarova M, Orel M, Kouzmina G, Stary J, Blazek B, Pospisilova D. Bull Cancer; 2004 Apr 01; 91(4):E80-9. PubMed ID: 15562558 [Abstract] [Full Text] [Related]
13. Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia. Pieters R, Hongo T, Loonen AH, Huismans DR, Broxterman HJ, Hählen K, Veerman AJ. Br J Cancer; 1992 May 01; 65(5):691-7. PubMed ID: 1350207 [Abstract] [Full Text] [Related]
14. In vitro drug resistance profiles of adult acute lymphoblastic leukemia: possible explanation for difference in outcome to similar therapeutic regimens. Styczynski J, Wysocki M. Leuk Lymphoma; 2002 Feb 01; 43(2):301-7. PubMed ID: 11999561 [Abstract] [Full Text] [Related]
15. Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs. Kaspers GJ, Pieters R, Van Zantwijk CH, Van Wering ER, Van Der Does-Van Den Berg A, Veerman AJ. Blood; 1998 Jul 01; 92(1):259-66. PubMed ID: 9639525 [Abstract] [Full Text] [Related]
17. Relationship between in vitro chemosensitivity assessed with MTT assay and clinical outcomes in 103 patients with acute leukemia. Jun KR, Jang S, Chi HS, Lee KH, Lee JH, Choi SJ, Seo JJ, Moon HN, Im HJ, Park CJ. Korean J Lab Med; 2007 Apr 01; 27(2):89-95. PubMed ID: 18094557 [Abstract] [Full Text] [Related]
18. Ex vivo drug resistance profile in childhood acute myelogenous leukemia: no drug is more effective in comparison to acute lymphoblastic leukemia. Styczynski J, Wysocki M, Debski R, Juraszewska E, Malinowska I, Stanczak E, Ploszynska A, Stefaniak J, Mazur B, Szczepanski T. Leuk Lymphoma; 2002 Sep 01; 43(9):1843-8. PubMed ID: 12685842 [Abstract] [Full Text] [Related]
20. Two groups of Philadelphia chromosome-positive childhood acute lymphoblastic leukemia classified by pretreatment multidrug sensitivity or resistance in in vitro testing. Hongo T, Okada S, Inoue N, Yamada S, Yajima S, Watanabe C, Fujii Y, Horikoshi Y. Int J Hematol; 2002 Oct 01; 76(3):251-9. PubMed ID: 12416736 [Abstract] [Full Text] [Related] Page: [Next] [New Search]